Ureteroscope Market Size & Share 2026 - 2034

Ureteroscope Market Size

The global ureteroscope market size was valued at USD 1.26 billion in 2025. The market is anticipated to grow from USD 1.33 billion in 2026 to USD 2.13 billion in 2034, growing at a CAGR of 6% from 2026 to 2034. The market is witnessing robust growth, primarily driven by the rising incidence of kidney stones, urinary tract infections (UTIs), and other urological disorders, alongside the growing preference for minimally invasive treatment options.

According to the National Institutes of Health (NIH), kidney stone disease affected nearly 10% of the global population in 2023, with increasing obesity, dietary changes, genetic factors, and inadequate hydration contributing to the growing disease burden. At the same time, UTIs continue to impact millions worldwide, with Greater Boston Urology reporting that approximately 10 in 25 women and 3 in 25 men in the U.S. experience UTI symptoms during their lifetime. These trends are accelerating demand across the ureteroscopy market, as healthcare providers increasingly rely on advanced visualization technologies for faster diagnosis and effective treatment.

Modern ureteroscopes—including flexible, disposable, and single-use ureteroscopes—offer superior maneuverability, high-definition imaging, and improved infection control, making them an essential part of contemporary endourology procedures. The growing adoption of disposable ureteroscope market solutions is further supported by their ability to reduce cross-contamination risks, eliminate reprocessing costs, and improve workflow efficiency in hospitals and ambulatory surgical centers.

As a result, the ureteroscopy devices market continues to benefit from ongoing technological innovations and increasing procedural volumes worldwide. Rising investments in digital imaging, enhanced endoscopic platforms, and patient-centric minimally invasive care are expected to further strengthen the ureteroscopes market, creating significant commercial opportunities for manufacturers while improving clinical outcomes for patients undergoing kidney stone removal, ureteral stricture management, and other urinary tract interventions.

Ureteroscope Market Trends

The ureteroscope market is expanding as continuous innovations in ureteroscopy technology improve the diagnosis and treatment of urinary tract disorders, particularly kidney stones. Modern ureteroscopy devices now integrate high-definition (HD) and 4K imaging, enabling superior visualization of the urinary tract, more accurate stone detection, and greater procedural precision, which directly supports improved clinical outcomes and shorter recovery times. Manufacturers in the ureteroscopy devices market are also introducing advanced flexible and rigid ureteroscopes, allowing urologists to choose the most suitable instrument based on patient anatomy and procedural complexity.

A major trend shaping the disposable ureteroscope market and single-use ureteroscopes market is the growing preference for sterile, single-use devices that minimize cross-contamination risks, eliminate reprocessing requirements, and reduce maintenance costs for healthcare facilities. At the same time, reusable ureteroscopes continue to gain technological upgrades through enhanced durability, miniaturized designs, and improved deflection capabilities, making complex stone management procedures more efficient.

Another notable advancement is the integration of robotic-assisted ureteroscopy systems, which enhance instrument control, improve maneuverability within the urinary tract, reduce surgeon fatigue during lengthy procedures, and support consistent treatment outcomes. These innovations are strengthening procedural efficiency across hospitals and ambulatory surgical centers while increasing the adoption of next-generation ureteroscopy solutions worldwide.

As healthcare providers continue investing in advanced endourology technologies and minimally invasive treatment options, the global ureteroscopes market is expected to witness sustained growth, supported by rising demand for high-performance visualization systems, flexible and single-use ureteroscopes, and technologically advanced surgical platforms. Organizations seeking deeper competitive insights or procurement details can also request a quote for ureteroscope market intelligence to evaluate emerging opportunities, technology trends, and regional growth potential.

Ureteroscope Market Analysis

Based on product, the global market is segmented into flexible ureteroscope and rigid ureteroscope. The flexible ureteroscope segment accounted for the leading market share and was valued at USD 926 million in 2025.
 

• Flexible ureteroscopes are developed to treat problems like ureteral strictures, kidney stones, and tumors in the urinary system.
   
• Their design makes it easier to move around, which makes it less challenging for urologists to move through the complicated structure of the urinary tract.
   
• In addition, ongoing improvements in imaging technology and materials science are making these devices even better, which makes them even more popular in the market.
   

Based on usability, the ureteroscope market is segmented into reusable ureteroscopes and disposable ureteroscopes. The reusable ureteroscopes segment accounted for the leading market share and was valued at around USD 989 million in 2025.
 

• Reusable ureteroscopes are made to last, using high-quality materials that can handle endoscopy sterilization and can be used many times. These instruments are known for their longevity, which directly correlates to cost savings for healthcare facilities.
   
• Moreover, their design is often sophisticated, featuring advanced optics and flexible mechanisms that facilitate better navigation through the urinary tract.
   
• Thus, urologists can perform intricate procedures with enhanced precision and accuracy. This usability is particularly important in complex cases, where the anatomy may be challenging to navigate.
   

Based on application, the ureteroscope market is categorized into urolithiasis, urethral stricture, urinary tract infections, and other applications. The urolithiasis segment accounted for the leading share in the market in 2025 and is expected to reach around USD 926 million in 2034.
 

• Urolithiasis affects a substantial portion of the population across different age groups. For instance, according to Science Direct, urolithiasis is one of the most common urologic diseases worldwide, with an estimated prevalence ranging from 1% to 13% in different regions across the globe. The condition can lead to significant patient discomfort, urinary tract obstruction, and various complications if left untreated, emphasizing the need for efficient treatment options.
   
• When it comes to the management of urolithiasis, ureteroscopes are invaluable. These flexible endoscopes allow healthcare professionals to visualize and navigate the urinary tract effectively, facilitating the removal or fragmentation of stones through minimally invasive surgical techniques.

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the ureteroscope market is classified into hospitals, ambulatory surgical centers, and other end users. In 2025, the hospitals segment held the highest market share and is expected to showcase significant growth over the analysis period.
 

• Hospitals are designed to handle a wide range of medical conditions and provide a continuum of care. They often have specialized urology departments equipped with the necessary resources for surgeries and treatments, making them the primary setting for ureteroscopic procedures.
   
• Moreover, hospitals typically invest in the latest medical technologies. This includes high-definition ureteroscopes with advanced imaging capabilities and minimally invasive tools for stone removal and other procedures, creating an environment where cutting-edge treatments can be administered effectively.

The North America ureteroscope market accounted for the leading share and was valued at USD 591.5 million in 2025. Favorable reimbursement policies, coupled with a rise in awareness levels and increasing prevalence of urolithiasis, are expected to drive regional growth.
 

The U.S. market size reached USD 557.4 million in 2025, growing from USD 526.3 million in 2024.
 

• The U.S. holds a dominant market share in the ureteroscope market, driven by a robust healthcare system and advanced technological infrastructure.
   
• The high prevalence of urological diseases, including kidney stones and other urinary tract disorders, further fuels the demand for ureteroscopic procedures.
   
• Additionally, the presence of leading medical device manufacturers and ongoing innovations in imaging technology contribute to the growth of the market in the U.S., making it a key player in the global ureteroscope landscape.
   

The Europe ureteroscope market accounted for a significant revenue share and was valued at around USD 281 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• The significant market share of Europe in the market is characterized by its well-established healthcare systems and widespread adoption of minimally invasive surgical techniques.
   
• Countries like Germany, France, and the UK are at the forefront of innovation in urological devices, benefiting from strong research and development activities.
   
• The rise in healthcare expenditures and the growing emphasis on patient-centric care also drive market growth, with European nations increasingly focusing on improving surgical outcomes through advanced ureteroscopic technologies.
   

The Germany ureteroscope market is expected to witness considerable growth over the analysis period.
 

• Germany stands out within Europe as a significant contributor to the market, largely due to its advanced healthcare infrastructure and strong focus on medical research.
   
• With a high number of urological procedures performed annually, the demand for ureteroscopes remains robust.
   
• The presence of leading medical technology companies and a high rate of adoption of new technologies further enhances Germany's market share, setting a benchmark for quality and innovation in the field of urology.
   

The Asia Pacific ureteroscope market is anticipated to grow at the highest CAGR of 8.1% during the analysis timeframe.
 

• The Asia Pacific region is experiencing rapid growth in the market, driven by increasing urbanization, changing lifestyles, and rising incidences of kidney-related ailments.
   
• Countries such as India, Japan, and China are seeing enhanced investments in healthcare infrastructure, leading to greater availability of advanced medical devices.
   
• Additionally, initiatives by governments to improve healthcare access and affordability contribute to the rising adoption of ureteroscopic procedures in the region.
   

China ureteroscope market is predicted to grow significantly over the forecast period.
 

• China is a dominant player in the market within the Asia Pacific region, owing to its vast population and increasing healthcare needs.
   
• The rising prevalence of urological diseases, coupled with ongoing healthcare reforms aimed at enhancing service delivery, has led to an uptick in ureteroscopic procedures.
   
• Furthermore, the government's push for healthcare modernization and technological advancement has fostered a conducive environment for market growth, positioning China as a key contributor to the market.
   

Brazil is experiencing significant growth in the Latin America ureteroscope market and is anticipated to record robust growth throughout the forecast period.
 

• In South America, Brazil is the leading market for ureteroscopes, propelled by an expanding healthcare system and growing public awareness regarding urological health.
   
• The country's initiatives to improve healthcare access and reduce waiting times for surgical procedures have stimulated demand for advanced surgical instruments.
   
• Additionally, Brazilian hospitals increasingly adopt minimally invasive technologies, which enhances the market for ureteroscopes and positions Brazil as a significant player in the regional landscape.
   

Saudi Arabia ureteroscope market is poised to witness substantial growth in the Middle East and Africa market during the forecast period.
 

• Saudi Arabia holds a notable position in the market within the Middle East, characterized by significant investments in healthcare infrastructure and a growing focus on advanced medical technologies.
   
• Ongoing healthcare reforms and the adoption of international standards in clinical practice are driving the demand for ureteroscopic procedures.
   
• This is further supported by increasing disposable incomes among the population, enabling more patients to seek advanced urological care.
   

Ureteroscope Market Share

Companies operating in the ureteroscope industry are actively investing in expanding their product lines while enhancing technical performance and user experience. Leading players, including Boston Scientific, Ambu, and OLYMPUS, are focusing on developing advanced ureteroscopes with improved imaging capabilities, ergonomic designs, and enhanced maneuverability. These advancements aim to simplify procedures, reduce surgery time, and ultimately improve patient outcomes. The top 5 players in the market collectively hold a share of 35%, with a focus on harnessing innovative technologies to meet the growing demand for effective endoscopic solutions.
 

Ureteroscope Market Companies

Few of the prominent players operating in the ureteroscope industry include:

• Ambu
• BD
• Boston Scientific
• Coloplast
• Dornier MedTech
• neoscope
• OLYMPUS
• OPCOM Medical
• PUSEN
• RICHARD WOLF
• STORZ
• Stryker
• Boston Scientific excels in innovative ureteroscope technology and offers a comprehensive range of products tailored for urologists. Their minimally invasive solutions enhance patient outcomes, supported by strong clinical evidence and extensive professional training.
   
• Ambu specializes in single-use ureteroscopes designed for maximum efficiency and safety, minimizing cross-contamination risks. Their lightweight, user-friendly devices facilitate quick setup and streamline surgical workflows.
   

Ureteroscope Industry News

• In May 2026, Olympus signed a definitive agreement to acquire BioProtect Ltd. for USD 270 million (subject to customary adjustments). The acquisition expands Olympus' urology and oncology portfolio, strengthening technologies used in prostate cancer procedures alongside its endoscopy business.
   
• In February 2026, Boston Scientific reported FY2025 net sales of USD 20 billion, up 19.9%, while its Urology business generated USD 2.7 billion, increasing 23.1% year over year. The company's strong urology performance supports continued investment in endourology technologies, including ureteroscopy solutions.

The ureteroscope market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Flexible ureteroscope
• Rigid ureteroscope

Market, By Usability

• Reusable ureteroscopes
• Disposable ureteroscopes

Market, By Application

• Urolithiasis
• Urethral stricture
• Urinary tract infections
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE